<scp>MRI</scp> evidence of gray matter loss in <scp>COVID</scp>‐19 patients with cognitive and olfactory disorders

Abstract

Our MRI findings show that COVID-19-related olfactory and cognitive disorders both induce GM atrophy, although at different degrees of severity, likely indicative of neurodegeneration and neuroinflammation.